Login
Login

APHRC Online Microdata Library
  • Home
  • About APHRC
  • Datasets
  • Collections
  • Citations
  • Resources
  • How to use it?
  • Why sharing data?
  • Contact us
    Home / Central Data Catalog / HEALTH_AND_WELL-BEING / DDI-KEN-APHRC-GEGO-2021-V1.0 / variable [V123]
Health_and_Well-Being

Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya, GECO-Kenya

Kenya, , 2021 - 2023
Health and Well-Being (HaW)
Gershim Asiki,MD,Phd
Last modified November 26, 2024 Page views 38606 Documentation in PDF Metadata DDI/XML JSON
  • Study description
  • Documentation
  • Data Description
  • Get Microdata
  • Data files
  • GECO_FinalData1
CSV JSON

(iii) Duration of use (q3p8c3)

Data file: GECO_FinalData1

Overview

vald 485
invd 15
Interval discrete
Decimal 0
Range 1 - 96

Questions and instructions

Literal question
Think about the 3 months after [COVID]. Please indicate:
Fikiria kuhusu miezi 3 baada ya [COVID], kisha ueleze;
(c) Duration (e.g. used for only one month; for three months)
Muda (k.m. kutumika kwa mwezi mmoja tu; kwa miezi mitatu)
Categories
Value Category Cases
1 (a) one month only 234
48.2%
2 (b) two months 12
2.5%
3 (c) three months 154
31.8%
96 (96) Other specify 85
17.5%
Sysmiss 15
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Question pretext
Medications
Has this changed in [COVID] period = the time you were most affected [if applicable]
Question post text
N/A
Interviewer instructions
N/A

Description

Text
The question was asked to patients with type 2 diabetes to indicate the duration they used insulin during the three months of COVID-19 pandemic, specifically between March and June 2020.
Universe
Patients with type 2 diabetes

others

Notes
"(iii) Duration of use"
APHRC Microdata Portal

© APHRC Microdata Portal, All Rights Reserved. Slot Online